Y Takasaki

454 total citations
7 papers, 413 citations indexed

About

Y Takasaki is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Y Takasaki has authored 7 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Radiology, Nuclear Medicine and Imaging and 1 paper in Critical Care and Intensive Care Medicine. Recurrent topics in Y Takasaki's work include Monoclonal and Polyclonal Antibodies Research (2 papers), RNA Research and Splicing (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Y Takasaki is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (2 papers), RNA Research and Splicing (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Y Takasaki collaborates with scholars based in Japan, Sweden and United States. Y Takasaki's co-authors include Eng M. Tan, J S Deng, Richard A. Houghten, Elina Tan, Göran Roos, J P Huff, Göran Landberg, Kinji Tsukada, Kozo Takase and Junichi Yata and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Biochemical and Biophysical Research Communications.

In The Last Decade

Y Takasaki

6 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y Takasaki Japan 5 224 84 74 61 57 7 413
J S Deng United States 9 244 1.1× 78 0.9× 118 1.6× 140 2.3× 67 1.2× 15 596
L Severinsson Sweden 7 301 1.3× 98 1.2× 64 0.9× 107 1.8× 107 1.9× 8 505
Richard Torres United States 7 421 1.9× 123 1.5× 32 0.4× 33 0.5× 89 1.6× 9 607
Sara Droetto Italy 11 278 1.2× 59 0.7× 34 0.5× 124 2.0× 71 1.2× 11 492
Setsuo Ota Japan 10 336 1.5× 100 1.2× 48 0.6× 84 1.4× 35 0.6× 18 634
Carlo M. Croce United States 7 375 1.7× 115 1.4× 27 0.4× 43 0.7× 108 1.9× 8 504
Tapan Ganguly United States 12 289 1.3× 132 1.6× 33 0.4× 57 0.9× 98 1.7× 23 543
Cristina M. Junta Brazil 16 245 1.1× 63 0.8× 118 1.6× 148 2.4× 56 1.0× 41 564
Ton de Wit Netherlands 8 476 2.1× 90 1.1× 23 0.3× 44 0.7× 58 1.0× 10 582
Martin A. Julius United States 9 687 3.1× 70 0.8× 34 0.5× 60 1.0× 109 1.9× 10 799

Countries citing papers authored by Y Takasaki

Since Specialization
Citations

This map shows the geographic impact of Y Takasaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Takasaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Takasaki more than expected).

Fields of papers citing papers by Y Takasaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Takasaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Takasaki. The network helps show where Y Takasaki may publish in the future.

Co-authorship network of co-authors of Y Takasaki

This figure shows the co-authorship network connecting the top 25 collaborators of Y Takasaki. A scholar is included among the top collaborators of Y Takasaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Takasaki. Y Takasaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Takasaki, Y, et al.. (2023). High expression of PKCλ and ALDH1A3 indicates a poor prognosis, and PKCλ is required for the asymmetric cell division of ALDH1A3-positive cancer stem cells in PDAC. Biochemical and Biophysical Research Communications. 669. 85–94. 6 indexed citations
2.
Murata, Atsuhiko, et al.. (1999). [Does the present medical care system satisfy patients with home oxygen therapy (HOT) and home therapy with assisted ventilation (HTAV) in Japan?: an answer from a questionnaire analysis].. PubMed. 26 Suppl 2. 207–12.
3.
Roos, Göran, Göran Landberg, J P Huff, et al.. (1993). Analysis of the epitopes of proliferating cell nuclear antigen recognized by monoclonal antibodies.. PubMed. 68(2). 204–10. 57 indexed citations
4.
Takase, Kozo, K. Yamamoto, Junichi Yata, et al.. (1992). Reversible G1 arrest induced by dimethyl sulfoxide in human lymphoid cell lines: kinetics of the arrest and expression of the cell cycle marker proliferating cell nuclear antigen in Raji cells.. PubMed. 3(8). 515–21. 33 indexed citations
5.
Sato, Chikara, Kunihide Nishizawa, Kiyoshi Nose, et al.. (1986). Intranuclear appearance of the phosphorylated form of cytoskeleton-associated 350-kDa proteins in U1-ribonucleoprotein regions after growth stimulation of fibroblasts.. Proceedings of the National Academy of Sciences. 83(19). 7287–7291. 15 indexed citations
6.
Hashimoto, H, Y Takasaki, Yoshito Kumagai, et al.. (1985). [Studies on the 1982 revised criteria for the classification of systemic lupus erythematosus].. PubMed. 25(1). 2–7. 1 indexed citations
7.
Takasaki, Y, J S Deng, & Eng M. Tan. (1981). A nuclear antigen associated with cell proliferation and blast transformation.. The Journal of Experimental Medicine. 154(6). 1899–1909. 301 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026